Key Takeaways CAH Q4 revenues are expected to rise 1.3% Y/Y to $60.67B on pharma volume and specialty strength.CAH EPS is projected at $2.03, up 10.3% Y/Y, aided by profit growth and share buybacks.CAH's medical segment recovery and at-home demand may offset macroeconomic headwinds.Cardinal Health, Inc. (CAH) is scheduled to report fourth-quarter fiscal 2025 results on Aug. 12, before market open.In the last reported quarter, the company’s adjusted earnings per share (EPS) of $2.35 surpassed the Zacks Conse ...